Detalles de la búsqueda
1.
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib.
Br J Haematol
; 184(3): 392-396, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30338509
2.
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.
Br J Haematol
; 172(3): 371-383, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597680
3.
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
Genes Chromosomes Cancer
; 54(4): 222-34, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645730
4.
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
Br J Haematol
; 185(1): 156-159, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29785734
5.
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
Am J Hematol
; 89(5): 480-6, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24415640
6.
TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy.
Haematologica
; 98(5): e59-61, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23403321
7.
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia.
Oncotarget
; 7(15): 20520-31, 2016 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26943037
8.
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.
Leuk Lymphoma
; 55(12): 2785-92, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24597984
Resultados
1 -
8
de 8
1
Próxima >
>>